Goodwin Procter advised Landmark Bio™ on the deal. Landmark Bio™ announced the opening of its state-of-the-art full-spectrum development and biomanufacturing facility in Watertown, Massachusetts. The 44,000 square-foot...
Landmark Bio’s Opening of State-of-the-art full-spectrum Development
CharterUP’s $60 Million Series A Financing Round
Goodwin Procter advised CharterUP on the deal. CharterUP announced the completion of its $60 million in Series A. The financing round was led by Tritium Partners. CharterUP...
AbbVie’s Acquisition of DJS Antibodies
Goodwin Procter advised DJS Antibodies on the deal. AbbVie (NYSE: ABBV) announced the acquisition of DJS Antibodies Ltd (“DJS”), a privately-held UK-based biotechnology company dedicated to discovering...
Bregal Sagemount’s Formation of Bregal Sagemount Fund IV
Goodwin Procter and Carey Olsen advised Bregal Sagemount on the deal. Bregal Sagemount announced the formation of Bregal Sagemount Fund IV, which hit its hard cap...
Accordion’s Acquisition of ABACI
Goodwin Procter advised ABACI on the deal. Accordion, a private equity-focused financial and technology consulting firm, announced that it has acquired ABACI, an Enterprise Resourcing Planning...
Hoxton Farms’ $22 Million Series A Financing
Goodwin Procter advised Hoxton Farms on the deal. Hoxton Farms announced its $22 million Series A financing. The funding round was led by Collaborative Fund and...
Sensat’s $20.5 Million Series B Financing
Goodwin Procter advised Sensat on the deal. Sensat announced its $20.5 million Series B financing. The funding round was led by National Grid Partners, the corporate venture...
Goodwin welcomes public M&A Partner Kirkie Maswoswe in New York
Global law firm Goodwin announced that Kirkie Maswoswe joined the firm’s Mergers & Acquisitions practice and Technology group as a partner, resident in the New York...
Immersive Labs’ $66 Million Financing Round
Goodwin Procter advised Ten Eleven Ventures on the deal. Ten Eleven Ventures announced its lead investment in Immersive Labs as part of a financing round raising $66...
Nimbus Therapeutics’ Research Collaboration and License Agreement with Eli Lilly and Co.
Goodwin Procter advised Nimbus Therapeutics on the deal. Nimbus Therapeutics announced its Research Collaboration and License Agreement with Eli Lilly and Company for the exclusive and worldwide...
nxyz’s $40 Million Series A Financing Round
Goodwin advised nxyz on the deal. Nxyz announced its $40 million Series A financing round. nxyz is a web3 platform that enables lightning-fast data infrastructure for blockchains....
The Rounds’ $38 Million Series A Financing
Gunderson Dettmer represented The Rounds on the deal while Goodwin Procter advised Redpoint Ventures and Andreessen Horowitz. The Rounds, a consumer goods delivery service company, announced...